{"title": "Cient\u00edficos europeos trabajan en vacunas nanotecnol\u00f3gicas contra el c\u00e1ncer", "author": "EFE", "url": "https://theobjective.com/sociedad/2020-06-16/cientificos-europeos-trabajan-en-vacunas-nanotecnologicas-contra-el-cancer/", "hostname": "theobjective.com", "description": "Cient\u00edficos de ocho pa\u00edses europeos, entre los que figuran onc\u00f3logos y qu\u00edmicos de La Rioja, emplear\u00e1n las \u00faltimas tecnolog\u00edas para construir", "sitename": "The Objective", "date": "2020-06-16", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Cient\u00edficos europeos trabajan en vacunas nanotecnol\u00f3gicas contra el c\u00e1ncer\nCient\u00edficos de ocho pa\u00edses europeos, entre los que figuran onc\u00f3logos y qu\u00edmicos de La Rioja, emplear\u00e1n las \u00faltimas tecnolog\u00edas para construir nanopart\u00edculas, que ser\u00e1n dirigidas, de manera espec\u00edfica, a las c\u00e9lulas del sistema inmune, con el objetivo de identificar y destruir tumores mediante el desarrollo de vacunas nanotecnol\u00f3gicas.\nPor qu\u00e9 es importante: la t\u00e9cnica que se emplear\u00e1 consiste en entrenar al sistema inmune del paciente para que ataque a las c\u00e9lulas tumorales, lo que requiere del desarrollo de vacunas terap\u00e9uticas -no preventivas- que permitan activar mecanismos de defensa en las primeras fases de la enfermedad. Lo que diferenciar\u00e1 este proyecto de varias vacunas que se desarrollan contra el c\u00e1ncer es \u00abla utilizaci\u00f3n de derivados no naturales, componentes semisint\u00e9ticos que potenciar\u00e1n la respuesta inmune\u00bb, seg\u00fan los responsables de esta investigaci\u00f3n en La Rioja, Alfredo Mart\u00ednez y Francisco Corzana, que han aclarado que, al tratarse de elementos que no aparecen como tales en el organismo, el sistema inmune los va a identificar claramente como algo extra\u00f1o.\nEl proyecto, que se ha presentado este martes en Logro\u00f1o, re\u00fane a 12 equipos de investigaci\u00f3n y cinco empresas asociadas de Italia, Reino Unido, Portugal, Austria, Noruega, Suiza, Holanda y Espa\u00f1a, representada a trav\u00e9s del Centro de Investigaci\u00f3n Biom\u00e9dica de La Rioja (Cibir) y de la Universidad de La Rioja (UR).\nCient\u00edficos del grupo de Qu\u00edmica Biol\u00f3gica de la UR, dirigido por Corzana, dise\u00f1ar\u00e1n y sintetizar\u00e1n ant\u00edgenos que contengan amino\u00e1cidos no naturales, con el objetivo de prolongar la vida de estas mol\u00e9culas en el organismo, as\u00ed como secuencias de prote\u00ednas glicosiladas -que contienen az\u00facares-, t\u00edpicas en algunos tumores.\nLos investigadores del Cibir estudiar\u00e1n, en modelos animales de laboratorio, la potencia de las vacunas, la respuesta inmune inducida y su potencial para reducir el crecimiento tumoral y las met\u00e1stasis. \u00abEs como si fuera un f\u00e1rmaco formado por unos componentes m\u00e1s resistentes, que potenciar\u00e1n el efecto contra el tumor\u00bb.\nAlfredo Mart\u00ednez, director del \u00c1rea Oncol\u00f3gica del Cibir, ha precisado que se trata de desarrollar \u00abuna vacuna inteligente, no solo producir anticuerpos frente a prote\u00ednas concretas del virus, sino, adem\u00e1s, utilizar las \u00faltimas tecnolog\u00edas \u2013nanopart\u00edculas con un n\u00facleo de oro\u2013 para que esto sea mucho m\u00e1s eficaz y m\u00e1s dirigido\u00bb.\nHa destacado \u00abel importante esfuerzo europeo\u00bb de este proyecto, con una financiaci\u00f3n europea de cuatro millones de euros, para tratar de llevar toda esa tecnolog\u00eda al campo de la oncolog\u00eda y, a ser posible, trasladar sus resultados al \u00e1mbito cl\u00ednico.\nTambi\u00e9n ha indicado que en la bibliograf\u00eda hay varios estudios que han conseguido algo parecido, pero lo importante de este proyecto radica en el alcance de la investigaci\u00f3n, que comenzar\u00e1 el pr\u00f3ximo 1 de octubre con una duraci\u00f3n de cuatro a\u00f1os y una previsi\u00f3n de que a la mitad se haya podido desarrollar la vacuna.", "language": null, "image": "https://theobjective.com/wp-content/uploads/2020/06/cientificos-europeos-desarrollan-vacunas-nanotecnologicas-contra-el-cancer.jpg", "pagetype": "article", "links": ["https://theobjective.com", "https://theobjective.com/newsletters", "https://theobjective.com/apoya-a-the-objective", "https://theobjective.com", "https://theobjective.com", "https://theobjective.com/newsletters", "https://theobjective.com/apoya-a-the-objective", "https://theobjective.com", "https://twitter.com/TheObjective_es", "https://www.instagram.com/theobjective_Es/", "https://www.facebook.com/theobjective.esp", "https://www.youtube.com/c/TheObjective_es", "https://open.spotify.com/user/theobjective_es?si=m4YyKsRFSKaAd11iC1pJrA", "https://es.linkedin.com/company/the-objective-media", "https://medium.com/@TheObjective", "https://www.tiktok.com/@theobjective", "https://theobjective.com/", "https://theobjective.com/espana/", "https://theobjective.com/etiqueta/elecciones-generales/", "https://theobjective.com/espana/politica/", "https://theobjective.com/espana/tribunales/", "https://theobjective.com/espana/andalucia/", "https://theobjective.com/etiqueta/cataluna/", "https://theobjective.com/espana/castilla-y-leon/", "https://theobjective.com/etiqueta/comunidad-de-madrid/", "https://theobjective.com/etiqueta/comunidad-valenciana/", "https://theobjective.com/etiqueta/pais-vasco/", "https://theobjective.com/economia/", "https://theobjective.com/etiqueta/macroeconomia/", "https://theobjective.com/etiqueta/telecos/", "https://theobjective.com/etiqueta/energia/", "https://theobjective.com/etiqueta/transporte/", "https://theobjective.com/etiqueta/banca/", "https://theobjective.com/economia/consumo/", "https://theobjective.com/elsubjetivo/", "https://theobjective.com/elsubjetivo/opinion/", "https://theobjective.com/autor/alvaro-nieto/", "https://theobjective.com/autor/felix-de-azua/", "https://theobjective.com/autor/fernando-savater/", "https://theobjective.com/autor/antonio-cano/", "https://theobjective.com/cultura/", "https://theobjective.com/etiqueta/literatura/", "https://theobjective.com/etiqueta/musica/", "https://theobjective.com/etiqueta/cine/", "https://theobjective.com/etiqueta/arte/", "https://theobjective.com/etiqueta/series/", "https://theobjective.com/sociedad/", "https://theobjective.com/etiqueta/salud/", "https://theobjective.com/sociedad/medioambiente/", "https://theobjective.com/lifestyle/", "https://theobjective.com/etiqueta/moda/", "https://theobjective.com/etiqueta/belleza/", "https://theobjective.com/etiqueta/sexualidad/", "https://theobjective.com/gastronomia/", "https://theobjective.com/etiqueta/recetas/", "https://theobjective.com/etiqueta/vinos/", "https://theobjective.com/etiqueta/restaurantes/", "https://theobjective.com/gente/", "https://theobjective.com/etiqueta/celebrities/", "https://theobjective.com/etiqueta/casa-real/", "https://theobjective.com/internacional/", "https://theobjective.com/etiqueta/guerra-ucrania-rusia/", "https://theobjective.com/deportes/", "https://theobjective.com/etiqueta/futbol/", "https://theobjective.com/etiqueta/formula-1/", "https://theobjective.com/etiqueta/baloncesto/", "https://theobjective.com/etiqueta/tenis/", "https://theobjective.com/etiqueta/golf/", "https://theobjective.com/motor/", "https://theobjective.com/etiqueta/coches/", "https://theobjective.com/etiqueta/motos/", "https://theobjective.com/etiqueta/movilidad/", "https://theobjective.com/etiqueta/dgt/", "https://theobjective.com/tecnologia/", "https://theobjective.com/tecnologia/videojuegos/", "https://theobjective.com/etiqueta/internet/", "https://theobjective.com/etiqueta/smartphones/", "https://theobjective.com/etiqueta/redes-sociales/", "https://theobjective.com/etiqueta/historia/", "https://theobjective.com/etiqueta/historias-de-la-historia/", "https://theobjective.com/medios/", "https://theobjective.com/medios/television/", "https://theobjective.com/medios/radio/", "https://theobjective.com/etiqueta/programas/", "https://theobjective.com/ultimas-noticias/", "https://theobjective.com/videos/", "https://theobjective.com/etiqueta/entrevistas/", "https://theobjective.com/etiqueta/el-purgatorio/", "https://theobjective.com/etiqueta/vidas-cruzadas/", "https://theobjective.com/podcasts/", "https://theobjective.com/etiqueta/al-tanto/", "https://theobjective.com/etiqueta/el-gris-importa/", "https://theobjective.com/etiqueta/sumario-de-tarde/", "https://theobjective.com/galerias/", "https://theobjective.com/productos-recomendados/", "https://informativoscanarias.theobjective.com/", "https://classpaper.theobjective.com/", "https://theobjective.com/quienes-somos/", "https://theobjective.com/principios-y-valores/", "https://theobjective.com/equipo/", "https://theobjective.com/firmas/", "https://theobjective.com/app/", "https://theobjective.com/escuela-ethos/", "https://theobjective.com/newsletters", "https://theobjective.com/apoya-a-the-objective", "https://theobjective.com/sociedad/", "https://theobjective.com/autor/efe/", "https://theobjective.com/autor/efe/", "//www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2020-06-16%2Fcientificos-europeos-trabajan-en-vacunas-nanotecnologicas-contra-el-cancer%2F", "//twitter.com/intent/tweet?url=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2020-06-16%2Fcientificos-europeos-trabajan-en-vacunas-nanotecnologicas-contra-el-cancer%2F&text=Cient%C3%ADficos%20europeos%20trabajan%20en%20vacunas%20nanotecnol%C3%B3gicas%20contra%20el%20c%C3%A1ncer&via=TheObjective_es", "//web.whatsapp.com/send?text=Cient%C3%ADficos%20europeos%20trabajan%20en%20vacunas%20nanotecnol%C3%B3gicas%20contra%20el%20c%C3%A1ncer | The Objective%20https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2020-06-16%2Fcientificos-europeos-trabajan-en-vacunas-nanotecnologicas-contra-el-cancer%2F", "https://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2020-06-16%2Fcientificos-europeos-trabajan-en-vacunas-nanotecnologicas-contra-el-cancer%2F&title=Cient%C3%ADficos%20europeos%20trabajan%20en%20vacunas%20nanotecnol%C3%B3gicas%20contra%20el%20c%C3%A1ncer", "//telegram.me/share/url?url=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2020-06-16%2Fcientificos-europeos-trabajan-en-vacunas-nanotecnologicas-contra-el-cancer%2F&text=Cient%C3%ADficos%20europeos%20trabajan%20en%20vacunas%20nanotecnol%C3%B3gicas%20contra%20el%20c%C3%A1ncer%20The Objective", "/cdn-cgi/l/email-protection#92ade1e7f0f8f7f1e6afc6f7b7a0a2e2e7f7f6f7b7a0a2fbfce6f7e0f7e1f3e0bcbcbcb4f0fdf6ebafd1fbf7fce6b7d1a1b7d3d6f4fbf1fde1b7a0a2f7e7e0fde2f7fde1b7a0a2e6e0f3f0f3f8f3fcb7a0a2f7fcb7a0a2e4f3f1e7fcf3e1b7a0a2fcf3fcfde6f7f1fcfdfeb7d1a1b7d0a1f5fbf1f3e1b7a0a2f1fdfce6e0f3b7a0a2f7feb7a0a2f1b7d1a1b7d3a3fcf1f7e0b7a0a2fae6e6e2e1b7a1d3b7a0d4b7a0d4e6faf7fdf0f8f7f1e6fbe4f7bcf1fdffb7a0d4e1fdf1fbf7f6f3f6b7a0d4a0a2a0a2bfa2a4bfa3a4b7a0d4f1fbf7fce6fbf4fbf1fde1bff7e7e0fde2f7fde1bfe6e0f3f0f3f8f3fcbff7fcbfe4f3f1e7fcf3e1bffcf3fcfde6f7f1fcfdfefdf5fbf1f3e1bff1fdfce6e0f3bff7febff1f3fcf1f7e0b7a0d4", "https://theobjective.com/autor/efe/", "https://theobjective.com/autor/efe/", "//www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2020-06-16%2Fcientificos-europeos-trabajan-en-vacunas-nanotecnologicas-contra-el-cancer%2F", "//twitter.com/intent/tweet?url=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2020-06-16%2Fcientificos-europeos-trabajan-en-vacunas-nanotecnologicas-contra-el-cancer%2F&text=Cient%C3%ADficos%20europeos%20trabajan%20en%20vacunas%20nanotecnol%C3%B3gicas%20contra%20el%20c%C3%A1ncer&via=TheObjective_es", "//web.whatsapp.com/send?text=Cient%C3%ADficos%20europeos%20trabajan%20en%20vacunas%20nanotecnol%C3%B3gicas%20contra%20el%20c%C3%A1ncer | The Objective%20https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2020-06-16%2Fcientificos-europeos-trabajan-en-vacunas-nanotecnologicas-contra-el-cancer%2F", "https://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2020-06-16%2Fcientificos-europeos-trabajan-en-vacunas-nanotecnologicas-contra-el-cancer%2F&title=Cient%C3%ADficos%20europeos%20trabajan%20en%20vacunas%20nanotecnol%C3%B3gicas%20contra%20el%20c%C3%A1ncer", "//telegram.me/share/url?url=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2020-06-16%2Fcientificos-europeos-trabajan-en-vacunas-nanotecnologicas-contra-el-cancer%2F&text=Cient%C3%ADficos%20europeos%20trabajan%20en%20vacunas%20nanotecnol%C3%B3gicas%20contra%20el%20c%C3%A1ncer%20The Objective", "/cdn-cgi/l/email-protection#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", "https://news.google.com/publications/CAAiELumQ8m_nwDuO-xzhLPkxhgqFAgKIhC7pkPJv58A7jvsc4Sz5MYY?ceid=ES:es&oc=3", "https://theobjective.com/etiqueta/cancer/", "https://theobjective.com/etiqueta/ciencia/", "https://theobjective.com/etiqueta/medicina/", "https://theobjective.com/etiqueta/salud/", "https://theobjective.com/etiqueta/vacunas/", "https://theobjective.com/apoya-a-the-objective/", "https://theobjective.com/sociedad/2020-06-21/sanidad-notifica-141-contagios-fallecido-las-ultimas-24-horas/", "https://theobjective.com/sociedad/2020-06-21/sanidad-notifica-141-contagios-fallecido-las-ultimas-24-horas/", "https://theobjective.com/sociedad/2020-06-23/sudafrica-epicentro-de-la-covid-19-en-africa-supera-los-100-000-casos/", "https://theobjective.com/sociedad/2020-06-23/sudafrica-epicentro-de-la-covid-19-en-africa-supera-los-100-000-casos/", "https://theobjective.com/sociedad/2020-06-22/directo-espana-enfrenta-su-primer-dia-laborable-de-la-nueva-normalidad/", "https://theobjective.com/sociedad/2020-06-22/directo-espana-enfrenta-su-primer-dia-laborable-de-la-nueva-normalidad/", "https://theobjective.com/sociedad/2020-06-21/chile-supera-italia-numero-contagios-242-355/", "https://theobjective.com/sociedad/2020-06-21/chile-supera-italia-numero-contagios-242-355/", "https://theobjective.com/sociedad/2020-06-23/china-suma-22-nuevos-casos-covid-19-13-pekin/", "https://theobjective.com/sociedad/2020-06-22/mundo-alcanza-los-884-millones-casos-covid-19-465-000-fallecidos/", "https://theobjective.com/sociedad/2020-06-22/estudios-cientificos-aseguran-la-inmunidad-al-covid-19-no-tendria-efecto-largo-plazo/", "https://theobjective.com/sociedad/2020-06-23/alemania-reconfina-una-region-por-un-nuevo-brote-de-coronavirus/", "https://theobjective.com/espana/", "https://theobjective.com/espana/politica/", "https://theobjective.com/espana/tribunales/", "https://theobjective.com/etiqueta/madrid/", "https://theobjective.com/etiqueta/cataluna/", "https://theobjective.com/espana/andalucia/", "https://theobjective.com/economia/", "https://theobjective.com/etiqueta/macroeconomia/", "https://theobjective.com/etiqueta/banca/", "https://theobjective.com/etiqueta/telecos/", "https://theobjective.com/etiqueta/energia/", "https://theobjective.com/etiqueta/transporte/", "https://theobjective.com/elsubjetivo/", "https://theobjective.com/elsubjetivo/opinion/", "https://theobjective.com/autor/alvaro-nieto/", "https://theobjective.com/autor/felix-de-azua/", "https://theobjective.com/autor/fernando-savater/", "https://theobjective.com/autor/antonio-cano/", "https://theobjective.com/sociedad/", "https://theobjective.com/cultura/", "https://theobjective.com/deportes/", "https://theobjective.com/internacional/", "https://theobjective.com/economia/consumo/", "https://theobjective.com/lifestyle/", "https://theobjective.com/gastronomia/", "https://theobjective.com/etiqueta/moda/", "https://theobjective.com/etiqueta/belleza/", "https://theobjective.com/etiqueta/sexualidad/", "https://theobjective.com/gente/", "https://theobjective.com/videos/", "https://theobjective.com/podcasts/", "https://theobjective.com/ultimas-noticias/", "https://theobjective.com/etiqueta/entrevistas/", "https://theobjective.com/branded-content/", "https://theobjective.com/etiqueta/vidas-cruzadas/", "https://theobjective.com/etiqueta/contraluz/", "https://theobjective.com/etiqueta/la-mirilla/", "https://theobjective.com/etiqueta/el-buzon-secreto/", "https://theobjective.com/etiqueta/historias-de-la-historia/", "https://theobjective.com/quienes-somos/", "https://theobjective.com/equipo/", "https://theobjective.com/newsletters/", "https://theobjective.com/apoya-a-the-objective/", "https://theobjective.com/escuela-ethos/", "https://theobjective.com/quienes-somos/", "https://theobjective.com/equipo/", "https://theobjective.com/politica-de-privacidad/", "https://theobjective.com/politica-de-cookies/", "https://theobjective.com/aviso-legal/", "https://theobjective.com/contactanos/", "https://theobjective.com/newsletters", "https://theobjective.com/terminos-y-condiciones", "https://theobjective.com/politica-de-privacidad", "https://theobjective.com"]}